Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

February 16, 2021February 16, 2021

Gout Treatment Found to ‘Significantly’ Lessen Fibromyalgia Pain

News

One month’s treatment with allopurinol, a medicine used for gout and high levels of uric acid, significantly lessened pain in women with fibromyalgia who failed to respond to conventional therapies, ... Read more

February 2, 2021February 2, 2021

Patients’ Cognitive Difficulties May Be Due to Poor Stress Response

News

Problems with memory and verbal skills in fibromyalgia patients are associated with lower daytime levels of salivary cortisol, a hormone involved in stress response, a study suggests. Its researchers recommend further work ... Read more

November 15, 2019November 15, 2019

New Phase 2 Trial to Test NYX-2925 as Potential Fibromyalgia Therapy

News

A new Phase 2 clinical trial will continue to assess the safety and effectiveness of the non-opioid small molecule candidate therapy NYX-2925, developed by Aptinyx, in fibromyalgia patients. NYX-2925 is an oral ... Read more

October 8, 2019October 8, 2019

Cymbalta at 60 mg Dose Effective at Easing Pain of Fibromyalgia, Review Study Reports

News

An approved medication, Cymbalta (duloxetine) is effective at easing pain in fibromyalgia (FM) patients, a large meta-analysis shows. A daily 60 mg dose is enough to trigger therapeutic benefits with a ... Read more

July 31, 2019July 31, 2019

Tonix Receives US Patent for Investigational Therapy TNX-102 SL to Treat Fibromyalgia

News

Tonix Pharmaceuticals has been granted a U.S. patent for its investigational therapy TNX-102 SL (cyclobenzaprine HCl sublingual tablets), designed to treat fibromyalgia, among other indications. Issued by the U.S. Patent ... Read more

July 25, 2019July 25, 2019

Mindfulness-based Stress Reduction Program as Add-On Therapy Lessens FM Symptoms, Study Finds

News

A mindfulness program to reduce stress, used as an add-on to standard treatment, lessens fibromyalgia (FM) symptoms, improves quality of life, and also is more cost effective than other traditional ... Read more

June 12, 2019June 12, 2019

NYX-2925 Continues to Significantly Reduce Pain Severity Marker in Phase 2 Trial, Top Line Data Shows

News

Aptinyx’s NYX-2925 treatment candidate continues to significantly reduce the levels of a brain biomarker associated with pain severity, called glutamine (Glx), in people with fibromyalgia, top line results of a ... Read more

June 6, 2019June 6, 2019

Reduced Pelvic Muscle Strength, Urinary Dysfunction Often Accompany Fibromyalgia, Study Suggests

News

Women with fibromyalgia (FM) show reduced strength in the pelvic muscles, which correlates with urinary dysfunction and worse quality of life, a study reports. The study, “Lower urinary tract symptoms ... Read more

March 26, 2019March 26, 2019

Mirogabalin May Help Lessen Neuropathic Pain in Fibromyalgia, Rat Study Shows

News

Mirogabalin besylate, a calcium channel blocker approved as a treatment for neuropathic pain in Japan and marketed under the brand name Tarlige, reduced pain scores in two rat models of ... Read more